Gastroenterology
Volume 133, Issue 2 , Pages 710-712 , August 2007

Intestinal Development: The Many Faces of Wnt Signaling

  • Archana Kapoor
  • ,
  • H. Joyce Li
  • ,
  • Andrew B. Leiter

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Andrew Leiter, MD, Division of Gastroenterology/Department of Medicine, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605. fax: (508) 856-4770.

  • Image Result

    The canonical Wnt pathway and signaling through β-catenin. In the absence of Wnt ligand, β-catenin is phosphorylated by glycogen synthase kinase-3 (GSK3) and targeted for degradation through destructi

    The canonical Wnt pathway and signaling through β-catenin. In the absence of Wnt ligand, β-catenin is phosphorylated by glycogen synthase kinase-3 (GSK3) and targeted for degradation through destruction complexes containing APC, Axin, and other proteins (left). As a result, Wnt target genes remain repressed. During active signaling, Wnt proteins bind to their receptors and inhibit phosphorylation of β-catenin by GSK3, thus preventing its degradation in APC complexes (right). As a result, stabilized β-catenin is redistributed from the cell membrane to the nucleus, where it interacts with TCF family transcription factors as a co-activator to activate target gene transcription. β-cat, β-catenin; APC, adenomatous polyposis coli; DVL, disheveled.

PII: S0016-5085(07)01170-5

doi: 10.1053/j.gastro.2007.06.029

Gastroenterology
Volume 133, Issue 2 , Pages 710-712 , August 2007